Literature DB >> 31481437

Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an In Vitro Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae.

Alba Ribera1, Eva Benavent1, Cristina El-Haj1, Joan Gomez-Junyent1, Fe Tubau2,3, Raul Rigo-Bonnin4, Javier Ariza1,5, Oscar Murillo6,5.   

Abstract

We compared the efficacies of meropenem alone and in combination with colistin against two strains of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae, using an in vitro pharmacodynamic model that mimicked two different biofilm conditions. Meropenem monotherapy achieved remarkable efficacy (even a bactericidal effect) under all conditions, whereas colistin was almost inactive and resistance emerged. The addition of colistin to meropenem produced no relevant benefits, in contrast to experiences with other microorganisms.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Klebsiella pneumoniaezzm321990; biofilms; colistin

Mesh:

Substances:

Year:  2019        PMID: 31481437      PMCID: PMC6811400          DOI: 10.1128/AAC.01230-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria.

Authors:  R H Eng; F T Padberg; S M Smith; E N Tan; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

2.  Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.

Authors:  D Rodríguez-Pardo; C Pigrau; J Lora-Tamayo; A Soriano; M D del Toro; J Cobo; J Palomino; G Euba; M Riera; M Sánchez-Somolinos; N Benito; M Fernández-Sampedro; L Sorli; L Guio; J A Iribarren; J M Baraia-Etxaburu; A Ramos; A Bahamonde; X Flores-Sánchez; P S Corona; J Ariza
Journal:  Clin Microbiol Infect       Date:  2014-06-14       Impact factor: 8.067

3.  Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.

Authors:  Suzana Meira Ribeiro; César de la Fuente-Núñez; Beverlie Baquir; Célio Faria-Junior; Octávio L Franco; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

4.  Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Phillip J Bergen; Brian T Tsuji; Jurgen B Bulitta; Alan Forrest; Jovan Jacob; Hanna E Sidjabat; David L Paterson; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

5.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

6.  In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.

Authors:  Wang Hengzhuang; Hong Wu; Oana Ciofu; Zhijun Song; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

7.  Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.

Authors:  Cristina El Haj; Oscar Murillo; Alba Ribera; Nuria Lloberas; Joan Gómez-Junyent; Fe Tubau; Pere Fontova; Carme Cabellos; Javier Ariza
Journal:  Int J Antimicrob Agents       Date:  2018-01-31       Impact factor: 5.283

8.  In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.

Authors:  Anima Poudyal; Benjamin P Howden; Jan M Bell; Wei Gao; Roxanne J Owen; John D Turnidge; Roger L Nation; Jian Li
Journal:  J Antimicrob Chemother       Date:  2008-10-15       Impact factor: 5.790

9.  Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis.

Authors:  Juan C Martínez-Pastor; Ernesto Muñoz-Mahamud; Félix Vilchez; Sebastián García-Ramiro; Guillem Bori; Josep Sierra; José A Martínez; Lluis Font; Josep Mensa; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

10.  Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae.

Authors:  Grace C Lee; David S Burgess
Journal:  J Clin Med Res       Date:  2013-02-25
View more
  1 in total

1.  Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii.

Authors:  Shixing Zhu; Jiayuan Zhang; Chu Song; Yuwei Liu; Charles Oo; M Tobias Heinrichs; Zhihua Lv; Yuanqi Zhu; Sherwin K B Sy; Pan Deng; Mingming Yu
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.